News

HeartFlow plans a $100M IPO to fund R&D and new products despite financial risks. Read about its prospects, challenges, and ...
The company reported revenue of $37.2 million in the first quarter, up 39% year-over-year, but said it has faced challenges ...
Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S.
Heartflow is once again looking for a path to go public, with a filing for a Nasdaq IPO. | The former Fierce Medtech Fierce ...
In a bold bid to electrify Wall Street and revolutionize how heart disease is diagnosed, Heartflow, a medical technology ...
This summary covers significant health news including FDA advisers rejecting Otsuka's PTSD treatment, Getinge exceeding ...
Heartflow, an artificial intelligence-based medical device software developer, filed for an initial public offering in the United States on Thursday. The U.S. IPO market is witnessing a renewed vigor ...
MIAX-parent Miami International Holdings on Friday reported a wider quarterly loss in its filing for a U.S. initial public ...
The week’s remaining deals came from small Asian issuers, led by Chinese supply chain management firm Majestic Ideal Holdings ...
“At Heartflow, we are working toward a new vision to transform coronary artery disease from the leading cause of death to a disease that can be managed for life,” said John Farquhar, president ...
Heartflow just raised $35.8 million. Its diagnostic software reconfigures medical imaging data, particularly from CT scans, to build 3D models of patients' coronary arteries for physicians to use.
HeartFlow recently filed a Form S-1 with the SEC to confirm its intent to complete an initial public offering (IPO) and go ...